Seeking adults with metastatic or Cholangiocarcinoma that can't be removed through surgery and hasn't responded to therapy for a study of an investigational drug for bile duct cancer.
Seeking men and women who have been diagnosed since January 1, 2020, with metastatic non-small cell lung cancer and have been or will be treated with immunotherapy, chemotherapy or a combination of the two for a study to develop a tool to help guide treatment decisions.
Seeking adults with locally advanced non-small cell lung cancer for a study of adding radiation therapy to standard treatment for non-small cell lung cancer that cannot be treated by surgery (inoperable).
Seeking adults aged 70 and older with stage IIIB-IV lung cancer for a study comparing immunotherapy and chemotherapy to immunotherapy alone.
Seeking people with small cell lung cancer that has spread to other parts of the body (metastatic) for a study of whether adding radiation therapy to the usual treatment is better, worse or the same as the usual treatment alone following chemo-immunotherapy.
Seeking adults whose Multiple Myeloma has returned after treatment (Relapsed or Refractory) for a study of an investigational drug combination.
Seeking adults whose non-small Cell Lung Cancer has spread to other parts of their body (Metastatic) and who have not yet been treated for metastatic non-small cell lung cancer for a study of an investigational drug combination.
Seeking adults with Stage III or IV melanoma skin cancer that will be treated with surgery for a study of an investigational drug combination.
Seeking women with ovarian cancer, fallopian tube or primary peritoneal cancer that has returned or has stopped responding to previous treatment for a study testing an investigational drug for tumors expressing a protein know as folate receptor alpha (FOLR1).
Seeking men and women with advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes for a study comparing targeted drug combinations
Seeking men and women with stage III or IV head and neck cancer for a study comparing two treatment options following tumor removal surgery.
Seeking men and women whose non-small cell lung cancer (NSCLC) has spread outside the lungs, and has a change in the gene called EGFR (epidermal growth factor receptor) and has not yet been treated for a study of an investigational drug combination.